You are absolutely correct. The buildout was because the treatment works and the screening hold likely had to have been because the treatment works as well. When flipper44 first reported that clean rooms were being installed an "all systems go" signal was given. The big question from that point on was how much company moves with regard to finances and company silence used to keep some unwelcome forces at bay would affect the share price. I wanted them to finance much more when the public rift with Mr. Neil Woodford occurred but I do not know what options they had at that point with financiers. Best wishes.
“you will be aware, the Department of Health has asked NICE to conduct an appraisal of DCVax-L for treating newly diagnosed glioblastoma Please note that following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin during mid-June 2018 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately mid-August 2018”